Pacific Biosciences Of California reported $2.1B in Market Capitalization this December of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Accelerate Diagnostics AXDX:US USD 152M 73M
Agilent A:US USD 35.98B 506M
Bruker BRKR:US USD 7.86B 1.51B
Danaher DHR:US USD 187.89B 3.56B
Fluidigm FLDM:US USD 87M 37M
General Electric GE:US USD 67.65B 2.17B
Illumina ILMN:US USD 29.97B 1.01B
Myriad Genetics MYGN:US USD 1.54B 74M
Nanostring Technologies NSTG:US USD 594M 4M
Pacific Biosciences Of California PACB:US USD 1.31B 313M
Perkinelmer PKI:US USD 15.19B 2.75B
Quidel QDEL:US USD 4.79B 1.72B
Roche Holding ROG:VX CHF 263.11B 68.64B
Thermo Fisher Scientific TMO:US USD 198.71B 13.96B
Waters WAT:US USD 16.14B 3.8B